We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Stem Cell Breakthrough Offers new Hope for Lung Disease Patients

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Stem Cell Breakthrough Offers new Hope for Lung Disease Patients"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
For the first time researchers have found a type of stem cell that could prove crucial in reducing injury and scarring in the lung and even generate new lung cells.

A recent study has revealed that human cells isolated from the placenta could potentially heal lung injuries in patients.

Lead researcher, associate professor Yuben Moodley (formerly of the Alfred Hospital and Monash University, Melbourne) who now works at the Lung Institute of Western Australia, at The University of Western Australia, and as a Physician at Royal Perth Hospital said: ‘The investigation could provide hope for patients suffering from lung damage.

‘In Australia one in four are affected by serious lung conditions.  Globally lung diseases cause many deaths and disabilities, with most lung conditions responding poorly to traditional medicines. Cellular therapies, although in the early stages of development, may form a vital part of future life-saving treatments.'

The research carried out in collaboration with Dr Ursula Manuelpillai, from the Monash Institute of Medical Research, is published in the June issue of the American Journal of Respiratory and Critical Care Medicine.

Co-author Emeritus Professor Alan Trounson, President of the California Institute of Regenerative Medicine (and former Director of Monash Immunology and Stem Cell laboratories) said: ‘This study makes a very significant contribution to the potential repair of lung injury.  It adopts a new approach to cell therapy utilizing a type of cell that is available in large numbers and is particularly effective in lung repair.'

Professor Philip Thompson, director of LIWA stated: ‘It is critical to have people of Professor Moodley's calibre working in Perth, Australia, making significant advances in stem cell research. This can only result in better outcomes for people suffering with serious lung diseases, which are so common in our community.'